Skip to main content
. 2022 Nov 9;14(22):5500. doi: 10.3390/cancers14225500

Figure 4.

Figure 4

Overall survival (A), cancer-specific survival (B), relapse-free survival (C) and distant metastasis-free survival (D) according to phosphorylated (Thr 186) CDK9 (pCDK9) expression (low: ≤ median of 6; high: >median) in patients with cervical carcinoma treated with definitive CRT and BT.